8-K
Current Report
MoonLake Immunotherapeutics Filed Acc 0001213900-22-016984
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading ea157748-8k_helixacq.htm…